Table 1.
N (%) | All Sample | Participants with Current Cognitive Complaints (n = 657) | Participants without Current Cognitive Complaints (n = 736) | p |
---|---|---|---|---|
Age in years | ||||
21–44 | 322 (23.1%) | 226 (34.4%) | 96 (13.0%) | <0.001 |
45–64 | 940 (67.5%) | 413 (62.9%) | 527 (71.6%) | |
≥65 | 131 (9.4%) | 18 (2.7%) | 113 (15.4%) | |
Education level | ||||
Low | 44 (3.2%) | 17 (2.6%) | 27 (3.7%) | 0.284 |
Middle | 373 (26.8%) | 168 (25.6%) | 205 (27.8%) | |
High | 976 (70.0%) | 472 (71.8%) | 504 (68.5%) | |
Employment | ||||
Full-time or part-time | 787 (56.5%) | 384 (58.5%) | 403 (54.8%) | <0.001 |
Sick leave | 148 (10.6%) | 100 (15.2%) | 48 (6.5%) | |
Student, retired | 249 (17.9%) | 58 (8.8%) | 191 (25.9%) | |
Unemployed | 64 (4.6%) | 39 (5.9%) | 25 (3.4%) | |
Other | 145 (10.4%) | 76 (11.6%) | 69 (9.4%) | |
Married/partnered | ||||
No | 364 (26.1%) | 159 (24.2%) | 205 (27.9%) | 0.121 |
Yes | 1029 (73.9%) | 498 (75.8%) | 531 (72.1%) | |
Cancer without metastasis | ||||
Yes | 1236 (88.7%) | 575 (87.5%) | 661 (89.8%) | 0.177 |
No | 157 (11.3%) | 82 (12.5%) | 75 (10.2%) | |
Post-cancer curative treatment time | ||||
≤1 year | 373 (26.8%) | 210 (32.0%) | 163 (22.1%) | <0.001 |
1–3 years | 336 (24.1%) | 167 (25.4%) | 169 (23.0%) | |
≥3 years | 684 (49.1%) | 280 (42.6%) | 404 (54.9%) | |
BMI | ||||
Insufficient | 51 (3.7%) | 30 (4.6%) | 21 (2.9%) | 0.037 |
Normal | 802 (57.6%) | 377 (57.4%) | 425 (57.7%) | |
Overweight | 377 (27.0%) | 162 (24.6%) | 215 (29.2%) | |
Obesity | 163 (11.7%) | 88 (13.4%) | 75 (10.2%) | |
Frequency of psychotropic treatments | ||||
Never | 914 (65.6%) | 389 (59.2%) | 525 (71.3%) | <0.001 |
<1/month | 169 (12.1%) | 91 (13.8%) | 78 (10.6%) | |
>1/month and <1/week | 77 (5.5%) | 38 (5.8%) | 39 (5.3%) | |
>1/week | 233 (16.8%) | 139 (21.2%) | 94 (12.8%) | |
Self-reported sleep difficulties | ||||
Never | 95 (6.8%) | 34 (5.2%) | 61 (8.3%) | <0.001 |
Sometimes | 481 (34.5%) | 197 (30.0%) | 284 (38.6%) | |
Often | 817 (58.7%) | 426 (64.8%) | 391 (53.1%) | |
Physical activity | ||||
None or < once a week | 446 (32.0%) | 203 (30.9%) | 243 (33.0%) | 0.431 |
Once a week | 255 (18.3%) | 116 (17.7%) | 139 (18.9%) | |
Twice a week | 362 (26.0%) | 184 (28.0%) | 178 (24.2%) | |
≥3 times a week | 330 (23.7%) | 154 (23.4%) | 176 (23.9%) | |
History of neurological disease | ||||
No | 1316 (94.5%) | 625 (95.1%) | 691 (93.9%) | 0.311 |
Yes | 77 (5.5%) | 32 (4.9%) | 45 (6.1%) | |
Pre-existing knowledge 1 | ||||
No | 842 (60.5%) | 359 (54.6%) | 483 (65.6%) | <0.001 |
Yes | 551 (39.5%) | 298 (45.4%) | 253 (34.4%) |
1 Pre-existing knowledge about chemotherapy-associated cognitive problems. In bold in the table: significant results.